Primary |
Migraine |
75.2% |
Drug Use For Unknown Indication |
11.2% |
Product Used For Unknown Indication |
4.3% |
Asthma |
2.5% |
Headache |
1.2% |
Liver Disorder |
1.2% |
Vaginitis Bacterial |
1.2% |
Migraine Prophylaxis |
0.6% |
Multiple Allergies |
0.6% |
Nausea |
0.6% |
Rhinitis Allergic |
0.6% |
Urinary Tract Infection |
0.6% |
|
Drug Ineffective |
18.5% |
Vomiting |
9.2% |
Loss Of Consciousness |
6.2% |
Nausea |
6.2% |
Swollen Tongue |
6.2% |
Drug Exposure During Pregnancy |
4.6% |
Hypoaesthesia |
4.6% |
Pain |
4.6% |
Rash |
4.6% |
Urticaria |
4.6% |
Brain Natriuretic Peptide Increased |
3.1% |
Cardiomyopathy |
3.1% |
Hyperhidrosis |
3.1% |
Migraine |
3.1% |
Myocardial Infarction |
3.1% |
Overdose |
3.1% |
Pain In Extremity |
3.1% |
Paraesthesia |
3.1% |
Product Quality Issue |
3.1% |
Somnolence |
3.1% |
|
Secondary |
Migraine |
57.7% |
Product Used For Unknown Indication |
15.4% |
Migraine Prophylaxis |
11.5% |
Drug Use For Unknown Indication |
9.6% |
Cluster Headache |
3.8% |
Essential Tremor |
1.9% |
|
Cardiomyopathy |
8.3% |
Drug Ineffective |
8.3% |
Eye Pain |
8.3% |
Thrombocytopenia |
8.3% |
Visual Field Defect |
8.3% |
Drug Hypersensitivity |
4.2% |
Hypersensitivity |
4.2% |
Medication Error |
4.2% |
Migraine |
4.2% |
Non-hodgkin's Lymphoma |
4.2% |
Off Label Use |
4.2% |
Oropharyngeal Pain |
4.2% |
Overdose |
4.2% |
Pharmaceutical Product Complaint |
4.2% |
Photophobia |
4.2% |
Rash |
4.2% |
Therapeutic Response Decreased |
4.2% |
Therapeutic Response Delayed |
4.2% |
Tremor |
4.2% |
|
Concomitant |
Migraine |
27.6% |
Product Used For Unknown Indication |
14.6% |
Contraception |
8.0% |
Headache |
6.4% |
Pain |
4.8% |
Acne |
4.0% |
Hypertension |
3.8% |
Premenstrual Syndrome |
3.8% |
Depression |
3.2% |
Asthma |
2.8% |
Gastrooesophageal Reflux Disease |
2.6% |
Antidepressant Therapy |
2.4% |
Hormone Replacement Therapy |
2.4% |
Osteoarthritis |
2.2% |
Restless Legs Syndrome |
2.2% |
Rheumatoid Arthritis |
2.2% |
Sleep Disorder |
2.0% |
Glaucoma |
1.8% |
Menorrhagia |
1.8% |
Hepatitis C |
1.4% |
|
Pulmonary Embolism |
15.6% |
Vomiting |
7.8% |
Drug Ineffective |
6.7% |
Pain |
6.7% |
Tremor |
6.7% |
Deep Vein Thrombosis |
5.6% |
Nausea |
5.6% |
Pharmaceutical Product Complaint |
5.6% |
Weight Decreased |
4.4% |
Wrong Technique In Drug Usage Process |
4.4% |
Chest Pain |
3.3% |
Death |
3.3% |
Migraine |
3.3% |
Osteopenia |
3.3% |
Polycystic Liver Disease |
3.3% |
Vasospasm |
3.3% |
Weight Increased |
3.3% |
White Blood Cell Count Increased |
3.3% |
Abdominal Pain Upper |
2.2% |
Angioedema |
2.2% |
|